Shopping Cart (0)
My Account

Your Shopping Cart
Happy Holidays Chemcon2014Prognostic, Predictive, and POC: Biomarkers from Research to ClinicFlow Chemistry IndiaMicrofluidics and Lab on a Chip IndiaDiagnostics & Biomarkers - Online Event20% Discount OfferMarket Report SaleePoster Award PrizeBlogs

Epigenetics Market Trends 2011

Publisher: Select Biosciences
Published: January 2011
Pages: 76

Price:



This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases—especially various types of cancers.

This report presents the biological role of various epigenetic modifications in vivo and frames them in the context of specific biological events such as differentiation and disease.

This report also examines qualitative and in quantitative terms the research market landscape of epigenetics as it exists currently based on Select Biosciences bottom-up market research on this topic. Presented is market segmentation of epigenetics based on end-user research, based on technology utilization, and based on specific disease areas being studied. The primary market data are derived from a worldwide respondent pool that is highly-representative of the life science research community and therefore provides an excellent proxy for the understanding of the research trends operative in this space.

In addition to characterization of the epigenetics research marketplace, this report also presents an analysis of epigenetic biomarkers and their deployment as potential diagnostics. Also presented herein are the efforts vis-à-vis deployment of epigenetics as therapeutics—in this vein the clinical pipeline as it exists currently is presented.

This data-driven characterization of the epigenetics research landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans.

Extensive Worldwide Technical and Market Analyses Presented in this Report:

  • Characterization of Epigenetics Modifications
  • DNA Methylation, the Various Histone Modifications and their Qualitative Effects In Vivo
  • Epigenetic Silencing of Genes and Pathways: Mechanism and Effects
  • Tumor Suppressor Genes Silenced In Vivo
  • Specific Genes Modulated via Epigenetics In Various Diseases
  • Market Segmentation of Epigenetics by Disease Class
  • Epigenetics Market Segmentation
  • Epigenetics Market Segmentation by End-User Research Penetrance
  • Epigenetics Market Quantitative Segmentation by type of Modification Studied
  • Epigenetics Market Segmentation by Type of HDAC Studied
  • Penetrance of Product Vendors into Various Segments of the Epigenetics Marketplace: Quantitative Analysis
  • Emerging Trends and Themes in Epigenetics
  • Current Studies of microRNAs, non-coding RNAs, and Tumor Suppressor Genes in the Epigenetics Marketplace
  • Epigenetics-based Diagnostics: Epigenetics-based Biomarkers and their Current Status
  • Epigenetics-based Therapeutics: The current Clinical Pipeline of Approved and In-Development Therapeutics
  • More details of the scope of coverage of this industry report are found in the Table of Contents (TOC) for the report—see below for link to downloadable PDF of the TOC

Report Table of Contents (TOC) [Click Here to Download PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
Watch Keynote Presentation on Single-Cell Analysis
To view the keynote presentation given by Gajus Worthington, President of Fluidigm Corporation at the recent Single Cell Analysis Summit in San Diego click here.


Agenda Now Online - Clinical Applications of Stem Cells 26-27 February, Singapore
Agenda Now Online - Clinical Applications of Stem Cells 26-27 February, Singapore
The full agenda is now online! Register before 9 January 2015 to take advantage of our Early Bird offers.


International Bioprinting Congress 2014 - Testimonial
Dr. Mark DeCoster, Associate Professor, Biomedical Engineering, Louisiana Tech University, USA Hot, important growing area and Select Biosciences is helping to lead the way. The panel discussions were especially innovative.


Keynote Speaker- Dr. Anthony Mitchell Davies
We are thrilled to announce that Dr. Anthony Mitchell Davies from Center Director: Translational Cell Imaging at Institute of Health Biomedical Innovation will deliver his Keynote Talk at "CellTech India 2015" Conference.


International Bioprinting Congress 2014 - Testimonial
Professor Chua Chee Kai, Director NTU Additive Manufacturing Centre, Singapore. From a Co-Chair perspective, I am very pleased, the meeting was well organised and covered all aspects of the subject, from the scientific techniques through to intellectual property, moving forward in to the next advancements we can expect to see in the field. I am already looking forward to next year’s meeting.


International Bioprinting Congress 2014 - Testimonial
Dr. Stuart Williams, Director, University of Louisville, USA. Outstanding science, engineering, intellectual property and regulatory discussions

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com